THE EFFCT OF METFORMIN USE ON PROGNOSIS IN PANCREATIC CANCER PATIENTS

Esbah O., Eren T., Helvaci K., Guler T., Duran A. O., Bal O., ...More

ACTA MEDICA MEDITERRANEA, vol.30, no.2, pp.465-471, 2014 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 2
  • Publication Date: 2014
  • Journal Name: ACTA MEDICA MEDITERRANEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.465-471
  • Hacettepe University Affiliated: Yes

Abstract

Background: Several clinical studies have shown the effect of mefformine on survival in pancreatic cancer. We aimed to evaluate whether the use of mefformin in diabetic pancreatic cancer patients provides a survival advantage or not.